These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24991370)

  • 21. Improving diabetic patients' adherence to treatment and prevention of cardiovascular disease (Office Guidelines Applied to Practice-IMPACT Study)-a cluster randomized controlled effectiveness trial.
    Olomu A; Kelly-Blake K; Hart-Davidson W; Gardiner J; Luo Z; Heisler M; Holmes-Rovner M
    Trials; 2022 Aug; 23(1):659. PubMed ID: 35971135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence to and persistence with antidiabetic medications and associations with clinical and economic outcomes in people with type 2 diabetes mellitus: A systematic literature review.
    Evans M; Engberg S; Faurby M; Fernandes JDDR; Hudson P; Polonsky W
    Diabetes Obes Metab; 2022 Mar; 24(3):377-390. PubMed ID: 34779107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.
    Kengne AP; Brière JB; Zhu L; Li J; Bhatia MK; Atanasov P; Khan ZM
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jan; 24(1):143-154. PubMed ID: 37862440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus.
    Sicras-Mainar A; Navarro-Artieda R; Morano R; Ruíz L
    Endocrinol Nutr; 2016 Dec; 63(10):527-535. PubMed ID: 27744013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic impact of antidiabetic medications and glycemic control on managed care organizations: a review of the literature.
    Stephens JM; Botteman MF; Hay JW
    J Manag Care Pharm; 2006 Mar; 12(2):130-42. PubMed ID: 16515371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glycemic control and its association with sociodemographics, comorbid conditions, and medication adherence among patients with type 2 diabetes in southwestern Nigeria.
    Ibrahim AO; Agboola SM; Elegbede OT; Ismail WO; Agbesanwa TA; Omolayo TA
    J Int Med Res; 2021 Oct; 49(10):3000605211044040. PubMed ID: 34632841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(8):1-151. PubMed ID: 38130940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adherence to therapies for secondary prevention of cardiovascular disease: a focus on aspirin.
    Packard KA; Hilleman DE
    Cardiovasc Ther; 2016 Dec; 34(6):415-422. PubMed ID: 27473898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review.
    Tiktin M; Celik S; Berard L
    Curr Med Res Opin; 2016; 32(2):277-87. PubMed ID: 26565758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment adherence and the contemporary approach to treating type 2 diabetes mellitus.
    Kolars B; Minakovic I; Grabovac B; Zivanovic D; Mijatovic Jovin V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Jun; 168(2):97-104. PubMed ID: 38511473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(20):1-58. PubMed ID: 23074525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review.
    Park Y; Raza S; George A; Agrawal R; Ko J
    J Manag Care Spec Pharm; 2017 Aug; 23(8):893-901. PubMed ID: 28737993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization.
    Happe LE; Clark D; Holliday E; Young T
    J Manag Care Spec Pharm; 2014 Jul; 20(7):677-84. PubMed ID: 24967521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.